Clopidogrel as a Distinctive Cause of Insulin Autoimmune Syndrome: A Systematic Case Review

References

• Kittah NE, Vella A. Management of endocrine disease: pathogenesis and management of hypoglycemia. Eur J Endocrinol. 2017;177(1):R37–R47. doi:10.1530/EJE-16-1062
   PubMed Web of Science ®Google Scholar
• Censi S, Mian C, Betterle C. Insulin autoimmune syndrome: from diagnosis to clinical management. Ann Transl Med. 2018;6(17):335. doi:10.21037/atm.2018.07.32
   PubMed Web of Science ®Google Scholar
• Eisenbarth GS. Medical Intelligence Unit 13: Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. R.G. Landes Company; 1999.
   Google Scholar
• Calder GL, Ward GM, Sachithanandan N, MacIsaac RJ. Insulin autoimmune syndrome: a case of clopidogrel-induced autoimmune hypoglycemia. J Clin Endocrinol Metab. 2020;105(4):dgz301. doi:10.1210/clinem/dgz301
   PubMed Web of Science ®Google Scholar
• Hanefeld M, Frier BM, Pistrosch F. Hypoglycemia and cardiovascular risk: is there a major link? Diabetes Care. 2016;39(Suppl 2):S205–S209. doi:10.2337/dcS15-3014
   PubMed Web of Science ®Google Scholar
• Amiel SA, Aschner P, Childs B; International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–396. doi:10.1016/S2213-8587(18)30315-2
   PubMed Web of Science ®Google Scholar
• Collet JP, Thiele H, Barbato E, et al. 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J. 2021;42(14):1289–1367. doi:10.1093/eurheartj/ehaa575
   PubMed Web of Science ®Google Scholar
• Ji HH, Tang XW, Dong Z, Song L, Jia YT. Adverse event profiles of anti-CTLA-4 and anti-PD-1 monoclonal antibodies alone or in combination: analysis of spontaneous reports submitted to FAERS. Clin Drug Investig. 2019;39(3):319–330. doi:10.1007/s40261-018-0735-0
   PubMed Web of Science ®Google Scholar
• Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med. 2018;23(2):60–63. doi:10.1136/bmjebm-2017-110853
   PubMedGoogle Scholar
• Oest L, Roden M, Müssig K. Comparison of patient characteristics between East Asian and non-East Asian patients with insulin autoimmune syndrome. Clin Endocrinol. 2022;96(3):328–338. doi:10.1111/cen.14634
   PubMed Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372. doi:10.1136/bmj.n71
   Web of Science ®Google Scholar
• Bortolotti D, Mothe-Satney I, Ferrari P, et al. Spontaneous hypoglycaemia in the presence of both anti-insulin antibody and anti-insulin receptor antibody. Diabetes Metab. 2006;32(6):598–603. doi:10.1016/S1262-3636(07)70314-2
   PubMed Web of Science ®Google Scholar
• Yamada E, Okada S, Saito T, Osaki A, Ozawa A, Yamada M. Insulin autoimmune syndrome during the administration of clopidogrel. J Diabetes. 2016;8(4):588–589. doi:10.1111/1753-0407.12385
   PubMed Web of Science ®Google Scholar
• Rajpal A, Kassem LS, Moscoso-Cordero M, Arafah BM. Clopidogrel-induced insulin autoimmune syndrome: a newly recognized cause of hypoglycemia in a patient without diabetes. J Endocr Soc. 2017;1(9):1217–1223. doi:10.1210/js.2017-00316
   PubMedGoogle Scholar
• Hunter A, Graham U, Lindsay JR. Insulin autoimmune syndrome: a rare case of hypoglycaemia resolving with immunosuppression. Ulster Med J. 2018;87(1):34–36.
   PubMedGoogle Scholar
• Jiang Y, Wang L, Shi F, et al. Insulin autoimmune syndrome after exposure to clopidogrel: a case report. Endocr Metab Immune Disord Drug Targets. 2020;20(8):1355–1362. doi:10.2174/1871530320666191220111615
   PubMed Web of Science ®Google Scholar
• Yoshino H, Kawakami K, Kohriyama K, Yoshino G, Matsunaga S, Takechi H. Long-term follow-up of insulin autoimmune syndrome in an elderly patient. Clin Case Rep. 2020;8(12):2941–2944. doi:10.1002/ccr3.3150
   PubMed Web of Science ®Google Scholar
• Yang CC, Gu WJ, Lyu ZH, et al. 氯吡格雷致胰岛素自身免疫综合征一例 [One case report of insulin autoimmune syndrome induced by clopidogrel]. Zhonghua Nei Ke Za Zhi. 2021;60(1):55–57. Chinese. doi:10.3760/cma.j.cn112138-20200221-00109
   PubMedGoogle Scholar
• Rajan J, Cobos –salinas Leopoldo M, Cigarroa C. Insulin autoimmune syndrome after coronary stent placement. J Am Coll Cardiol. 2021;77(18_Supplement_1):1895. doi:10.1016/S0735-1097(21)03251-4
   Google Scholar
• de Castro T, Beier C, Terkamp C, et al. Insulin autoimmune syndrome: a rare, but important differential diagnosis of hypoglycemia. Internist. 2022;63(2):217–220. doi:10.1007/s00108-021-01180-0
   PubMed Web of Science ®Google Scholar
• Zhu Q, Zhao H, Qiu W, et al. Case report: recurrent autoimmune hypoglycemia induced by non-hypoglycemic medications. Front Immunol. 2022;13:855350. doi:10.3389/fimmu.2022.855350
   PubMed Web of Science ®Google Scholar
• Lupsa BC, Chong AY, Cochran EK, Soos MA, Semple RK, Gorden P. Autoimmune forms of hypoglycemia. Medicine. 2009;88(3):141–153. doi:10.1097/MD.0b013e3181a5b42e
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y, Omori Y, Iwamoto Y, Tokunaga K. Worldwide differences in the incidence of insulin autoimmune syndrome (Hirata disease) with respect to the evolution of HLA-DR4 alleles. Hum Immunol. 2000;61(2):154–157. doi:10.1016/s0198-8859(99)00144-5
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Kuwata S, Tokunaga K, et al. Strong association of insulin autoimmune syndrome with HLA-DR4. Lancet. 1992;339(8790):393–394. doi:10.1016/0140-6736(92)90080-m
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Hirata Y, Iwamoto Y. Drug-induced insulin autoimmune syndrome. Diabetes Res Clin Pract. 2009;83(1):e19–e20. doi:10.1016/j.diabres.2008.10.015
   PubMedGoogle Scholar
• Uchigata Y, Omori Y, Nieda M, Kuwata S, Tokunaga K, Juji T. HLA-DR4 genotype and insulin-processing in insulin autoimmune syndrome. Lancet. 1992;340(8833):1467. doi:10.1016/0140-6736(92)92654-x
   PubMed Web of Science ®Google Scholar
• Uchigata Y, Tokunaga K, Nepom G, et al. Differential immunogenetic determinants of polyclonal insulin autoimmune syndrome (Hirata’s disease) and monoclonal insulin autoimmune syndrome. Diabetes. 1995;44(10):1227–1232. doi:10.2337/diab.44.10.1227
   PubMed Web of Science ®Google Scholar
• Yuan T, Li J, Li M, et al. Insulin autoimmune syndrome diagnosis and therapy in a single Chinese center. Clin Ther. 2019;41(5):920–928. doi:10.1016/j.clinthera.2019.03.009
   PubMed Web of Science ®Google Scholar
• Yaturu S, DePrisco C, Lurie A. Severe autoimmune hypoglycemia with insulin antibodies necessitating plasmapheresis. Endocr Pract. 2004;10(1):49–54. doi:10.4158/EP.10.1.49
   PubMedGoogle Scholar
• Pujades-Rodriguez M, Morgan AW, Cubbon RM, Wu J, Rahimi K. Dose-dependent oral glucocorticoid cardiovascular risks in people with immune-mediated inflammatory diseases: a population-based cohort study. PLoS Med. 2020;17(12):e1003432. doi:10.1371/journal.pmed.1003432
   PubMed Web of Science ®Google Scholar
• Walker BR. Glucocorticoids and cardiovascular disease. Eur J Endocrinol. 2007;157(5):545–559. doi:10.1530/EJE-07-0455
   PubMed Web of Science ®Google Scholar
• Chen S, Qiang J, Tian R, et al. Clopidogrel-associated hypoglycemia and alternative antiplatelet therapy: a Real-World, Pharmacovigilance Study. Eur Heart J Cardiovasc Pharmacother. 2022:pvac050. doi:10.1093/ehjcvp/pvac050
   Web of Science ®Google Scholar